Windsor Creek Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Windsor Creek Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,600	Closed	-$1.03M	–	189
2020 Q1	$1.03M	Sell	9,600 -12,004	-56%	-$1.38M	0.37%	72
2019 Q4	$2.6K	Sell	21,604 -1,998	-8%	-$223K	0.69%	31
2019 Q3	$2.35M	Buy	23,602 +2,000	+9%	+$209K	0.58%	34
2019 Q2	$2.36M	Sell	21,602 -2,698	-11%	-$287K	0.64%	34
2019 Q1	$2.72M	Sell	24,300 -7,001	-22%	-$768K	0.73%	26
2018 Q4	$3.04M	Buy	+31,301	New	+$3.32M	0.97%	21

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Windsor Creek Advisors's IBB Position: Q2 2020 in Review

Windsor Creek Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 9,600 shares — an estimated $1.03M sold.

Windsor Creek Advisors first reported a position in IBB in Q4 2018 and held it in 6 quarters. The position peaked at $3.04M in Q4 2018. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

Windsor Creek Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
Windsor Creek Advisors sold 9,600 iShares Biotechnology ETF shares in Q2 2020, an estimated $1.03M.
Windsor Creek Advisors first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 6 quarters.
Windsor Creek Advisors's iShares Biotechnology ETF position peaked at $3.04M in Q4 2018.
766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Windsor Creek Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.